Trial record 1 of 1 for:
NCT06018116
A Canadian Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer. (CANUCK-01)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06018116 |
|
Recruitment Status :
Withdrawn
(Results of EV302 study do not make it feasible to complete a study in second line avelumab immunotherapy. The new standard of care make this study not pertinent.)
First Posted : August 30, 2023
Last Update Posted : February 15, 2024
|
Sponsor:
CHU de Quebec-Universite Laval
Collaborator:
Cancer Research Society
Information provided by (Responsible Party):
CHU de Quebec-Universite Laval
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Actual Primary Completion Date : | January 31, 2024 |
| Actual Study Completion Date : | February 12, 2024 |